Study of carmustine/bevacizumab in recurrent glioblastoma

Trial Profile

Study of carmustine/bevacizumab in recurrent glioblastoma

Phase of Trial: Phase II

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Carmustine (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2016 New trial record
    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top